AI
PRAX icon

Atria Investments’s Praxis Precision Medicines PRAX Stock Holding History

Atria Investments’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$335K Sell
1,001
-59
-6% -$18.7K ﹤0.01% 1779
2026
Q1 		$342K Buy
+1,060
New +$328K ﹤0.01% 1671

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Atria Investments's PRAX Position: Q2 2026 in Review

Atria Investments reduced its Praxis Precision Medicines (PRAX) stake by 5.6% in Q2 2026, selling an estimated $18.7K and leaving 1,001 shares worth $335K. The position accounts for ﹤0.01% of the portfolio, ranked #1779.

Atria Investments first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. The position peaked at $342K in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Atria Investments held 1,001 shares of Praxis Precision Medicines worth $335K as of Q2 2026.
  • Atria Investments sold 59 Praxis Precision Medicines shares in Q2 2026, an estimated $18.7K.
  • Praxis Precision Medicines made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #1779 holding.
  • Atria Investments first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • Atria Investments's Praxis Precision Medicines position peaked at $342K in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.